Nuwellis Reports Q3 2026 Results with 430 Basis Point Gross Margin Expansion and 24% Operating Loss Improvement
Nuwellis reported Q3 2026 net sales of $2.2 million, essentially unchanged from the prior-year quarter as the prior-year period benefited from $0.4 million in accumulated backorders. Operating loss improved 24% year-over-year to $2.1 million, driven by 430 basis points of gross margin expansion to 69.5% and a 13% reduction in operating expenses. Net loss was $2.0 million compared to net income of $0.5 million in Q3 2025, which included a $3.2 million non-cash gain from changes in fair value of warrant liabilitie...
Key takeaways
Operating loss improved 24% year-over-year to $2.1 million, driven by 430 basis points of gross margin expansion and 13% reduction in operating expenses.
Net sales were $2.2 million in Q3 2026, essentially unchanged from the prior-year quarter, but increased 12% sequentially from Q2 2026; year-to-date net sales increased 13% to $6.6 million.
Pediatric segment net sales increased 20% in Q3 2026 and 26% year-to-date, remaining a significant growth driver.
Console unit sales increased 88% year-to-date to 32 units compared with 17 units in the prior-year period, expanding the installed base for future recurring circuit revenue.
Gross margin expanded to 69.5% in Q3 2026 from 65.2% in the prior-year quarter, reflecting higher average selling prices and contract manufacturing benefits.
Company submitted 510(k) premarket notification to FDA seeking to expand Aquadex indication to pediatric patients weighing five kilograms and above.
Entered into co-promotion and distribution agreement with Atrility Medical for AtriAmp postoperative cardiac rhythm monitoring device and secured exclusive U.S. distribution rights for Zorro-Flow pediatric urine collection system.
Key metrics
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow NUWE in real time
Get material earnings, filing, IR, and earnings-call alerts by email.